()
 
 

Overview

Advanced Viral Research Corp. is a New York based biopharmaceutical company dedicated to improving patients' lives by researching, developing and bringing to market new and effective therapies for the control of symptoms associated with cancer and other serious diseases. Its initial compound AVR118 represents a new class of cytoprotective agent that targets, among other things, cachexia related disorders. AVR118 has also shown to have topical wound healing properties in animal models. Various degenerative conditions associated with body wasting (cachexia) such as cancer, HIV-AIDS and chronic inflammation are potential disease targets for AVR118 therapy.


Contact Information

200 Corporate Boulevard South
Yonkers, NY 10701

tel: 914-376-7383
fax: 914-376-7638


,  



Investor Relations


Management
tel:
fax:
e-mail:




Stock

Exchange: OTCBB
Industry: Drug Manufacturers - Other
Market Cap: $11.8M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.